Caishen.Co - Primary Data for China Secondary Investment and Stock Markets

Tag: Lilly Asia Ventures

CAR-T Biotech Firm Gracell Completes $100 Million Round

Chinese Gene Editing Startup EdiGene Raises RMB450 Million

DealShot: 17 Deals Worth $260 Million Including Lilly Asia Ventures, Meridian...

Cancer Innovative Drug Startup Inventis Bio Secures Over RMB1 Billion

Chinese Biotech Startup Singeron Secures $30M Round

DealShot: 12 Deals Exceeding $295 Million Involving CICC Capital, Lilly Asia...

Connect Biopharmaceuticals Raises $115M Series C Round

DealShot: 8 Deals Reaching $50 Million Including Lilly Asia Ventures, Sinovation...

Temasek Leads $70M Series C Round In Chinese Biotech Firm Abbisko

DealShot: 9 Deals Passing $160 Million Including Lilly Asia, GGV Capital...

Chinese Biotech Firm Transcenta Raises $100M Round

Chinese Genetic Testing Company Geneseeq Completes $114M Series D Round

Decheng Capital Leads $45M Series C Round In Chinese Biopharmaceutical Firm...

DealShot: 13 Deals Worth $160 Million Including Lilly Asia, Guozhong Venture...

Goldman Sachs Leads $62M Series D Round In Chinese CRO Firm...

Vivo Capital Leads $50M Series B Round In Chinese CRO Firm...

DealShot: 10 Deals Breaking $161 Million Counting Lilly Asia, K2VC, Sinovation...

Oceanpine Capital Leads $80M Series B Round In China-US Biotech Firm...

China’s Qiming Venture Partners Leads $37M In AI-Enabled Drug Discovery Start-Up

Qiming Venture Partners Leads $42M New Round In Chinese Biotech Start-Up

Chinese Clinical Stage Biotech Firm InventisBio Closes $70M Series C Round

DealShot: 12 Deals Topping $102 Million Involving Temasek, Eight Roads, Lilly...

Temasek Leads $85M Series B Round In Chinese Biotech Start-Up

GIC Leads $125M Series C Round In Chinese Cancer Diagnostics Firm...

Lilly Asia Ventures Receives $40M Commitment From US Pension Fund SFERS

Green Pine Leads Series Pre-B Plus Round In Chinese Genome Editing...

Hillhouse Capital Invests $35M Series A+ Round In Chinese Biopharmaceutical Firm...

Hillhouse, Quan Capital Lead $93M Series B Round In Biopharma Firm...

Vivo Capital, OrbiMed Lead $80M Series B Round In Biopharmaceutical Start-Up...

Temasek-Backed Biotech Firm Innovent Seeks To Raise Up To $500M In...

Agilent Technologies Acquires Qiming-backed Biotechnology Firm ACEA Biosciences

Want to see more data? Registered subscribers can see all the data.

   Register Now!
Caishen.Co - Primary Data for China Secondary Investment and Stock Markets
© 2020 China Money Network Limited. All Rights Reserved. Disclaimer: The views, opinions, forecasts, and statements made by our hosts and guests are the personal views of those respective individuals and may or may not be either endorsed or accepted by China Money Network Limited or the companies with which these individuals are employed.